Oxidation of Naringenin, Apigenin, and Genistein by Human Family 1 Cytochrome P450 Enzymes and Comparison of Interaction of Apigenin with Human P450 1B1.1 and Scutellaria P450 82D.1.


Journal

Chemical research in toxicology
ISSN: 1520-5010
Titre abrégé: Chem Res Toxicol
Pays: United States
ID NLM: 8807448

Informations de publication

Date de publication:
20 Nov 2023
Historique:
medline: 21 11 2023
pubmed: 3 10 2023
entrez: 2 10 2023
Statut: ppublish

Résumé

Naringenin, an initial synthesized flavanone in various plant species, is further utilized for production of many biologically active flavonoids, e.g., apigenin, eriodictyol, and genistein, by various plant enzymes including cytochrome P450s (P450s or CYPs). We examined how these flavonoids are oxidized by human P450 family 1 and 2A enzymes. Naringenin was principally oxidized at the 3'-position to form eriodictyol by CYP1 enzymes more efficiently than by CYP2A enzymes, and the resulting eriodictyol was further oxidized to two penta-hydroxylated products. In contrast to plant P450 enzymes, these human P450s did not mediate the desaturation of naringenin and eriodictyol to give apigenin and luteolin, respectively. Apigenin was oxidized at the C3' and C6 positions to form luteolin and scutellarein by these P450s. CYP1B1.1 and 1B1.3 had high activities in apigenin 6-hydroxylation with a homotropic cooperative manner, as has been observed previously in chrysin 6-hydroxylation (Nagayoshi et al.,

Identifiants

pubmed: 37783573
doi: 10.1021/acs.chemrestox.3c00229
doi:

Substances chimiques

naringenin HN5425SBF2
Apigenin 7V515PI7F6
Genistein DH2M523P0H
Flavanones 0
Cytochrome P450 Family 1 EC 1.14.14.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1778-1788

Auteurs

Haruna Nagayoshi (H)

Food Chemistry Section, Division of Hygienic Chemistry, Osaka Institute of Public Health, Higashinari-ku, Osaka 537-0025, Japan.

Norie Murayama (N)

Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.

Vitchan Kim (V)

Department of Biological Sciences, Konkuk University, Seoul 05025, Korea.

Donghak Kim (D)

Department of Biological Sciences, Konkuk University, Seoul 05025, Korea.

Shigeo Takenaka (S)

Department of Clinical Nutrition, Graduate School of Comprehensive Rehabilitation, Osaka Metropolitan University, Habikino, Osaka 583-8555, Japan.

Hiroshi Yamazaki (H)

Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan.

F Peter Guengerich (FP)

Department of Biochemistry, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232-0146, United States.

Tsutomu Shimada (T)

Department of Clinical Nutrition, Graduate School of Comprehensive Rehabilitation, Osaka Metropolitan University, Habikino, Osaka 583-8555, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH